Shares of Inovalis Real Estate Investment Trust (NASDAQ:INO) have been given an average rating of “Hold” by the thirteen brokerages that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is C$20.20.

INO has been the subject of a number of research analyst reports. HC Wainwright reissued a “buy” rating and set a $13.00 target price on shares of Inovalis Real Estate Investment Trust in a report on Tuesday, September 12th. BidaskClub raised Inovalis Real Estate Investment Trust from a “sell” rating to a “hold” rating in a report on Saturday, September 9th. ValuEngine cut Inovalis Real Estate Investment Trust from a “sell” rating to a “strong sell” rating in a report on Thursday. Maxim Group set a $12.00 target price on Inovalis Real Estate Investment Trust and gave the company a “buy” rating in a report on Wednesday, August 9th. Finally, Royal Bank of Canada initiated coverage on Inovalis Real Estate Investment Trust in a report on Wednesday, October 18th. They set an “outperform” rating and a $11.00 target price for the company.

Several hedge funds have recently bought and sold shares of the company. UBS Asset Management Americas Inc. grew its position in shares of Inovalis Real Estate Investment Trust by 0.4% in the second quarter. UBS Asset Management Americas Inc. now owns 25,710 shares of the company’s stock valued at $202,000 after purchasing an additional 92 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in shares of Inovalis Real Estate Investment Trust by 1.7% in the second quarter. The Manufacturers Life Insurance Company now owns 54,670 shares of the company’s stock valued at $428,000 after purchasing an additional 897 shares in the last quarter. PNC Financial Services Group Inc. grew its position in shares of Inovalis Real Estate Investment Trust by 5.0% in the second quarter. PNC Financial Services Group Inc. now owns 21,000 shares of the company’s stock valued at $164,000 after purchasing an additional 1,000 shares in the last quarter. American International Group Inc. grew its position in shares of Inovalis Real Estate Investment Trust by 7.1% in the first quarter. American International Group Inc. now owns 40,856 shares of the company’s stock valued at $270,000 after purchasing an additional 2,695 shares in the last quarter. Finally, Teachers Advisors LLC grew its position in shares of Inovalis Real Estate Investment Trust by 2.3% in the first quarter. Teachers Advisors LLC now owns 151,775 shares of the company’s stock valued at $1,005,000 after purchasing an additional 3,411 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/inovalis-real-estate-investment-trust-ino-receives-consensus-rating-of-hold-from-brokerages/1696901.html.

Inovalis Real Estate Investment Trust (NASDAQ INO) opened at C$4.74 on Friday. Inovalis Real Estate Investment Trust has a fifty-two week low of C$4.40 and a fifty-two week high of C$9.86.

Inovalis Real Estate Investment Trust (NASDAQ:INO) last announced its earnings results on Wednesday, November 8th. The company reported C($0.40) EPS for the quarter, missing analysts’ consensus estimates of C($0.25) by C($0.15). Inovalis Real Estate Investment Trust had a negative net margin of 46.44% and a negative return on equity of 33.16%. The firm had revenue of C$2.60 million for the quarter, compared to analyst estimates of C$10.27 million. During the same period in the previous year, the company earned ($0.28) EPS. Inovalis Real Estate Investment Trust’s revenue was down 79.2% compared to the same quarter last year.

The business also recently declared a monthly dividend, which was paid on Monday, October 16th. Stockholders of record on Friday, September 29th were given a $0.069 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 17.47%.

About Inovalis Real Estate Investment Trust

Inovio Pharmaceuticals, Inc (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company’s DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases.

Analyst Recommendations for Inovalis Real Estate Investment Trust (NASDAQ:INO)

Receive News & Ratings for Inovalis Real Estate Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalis Real Estate Investment Trust and related companies with Analyst Ratings Network's FREE daily email newsletter.